美国成人变应性鼻炎与不良睡眠参数的关联
基于2005-2006年美国国家健康与营养调查中5563名≥18岁成人的横断面研究,变应性鼻炎加权患病率为36.5%。调整协变量后,变应性鼻炎与睡眠潜伏期延长、失眠、睡眠呼吸暂停、睡眠障碍、使用助眠药物及日间功能障碍的 odds 升高相关。
要点
- 变应性鼻炎患者睡眠潜伏期≥30分钟的OR为1.24(95%CI 1.01-1.51)。
- 变应性鼻炎与失眠(OR 1.85)和睡眠呼吸暂停(OR 1.86)的 odds 升高相关。
- 变应性鼻炎患者使用助眠药物的OR为1.69(95%CI 1.23-2.33)。
核心结论
- 美国成人代表性样本中,变应性鼻炎与睡眠潜伏期延长、失眠、睡眠呼吸暂停、睡眠障碍、助眠药物使用及日间功能障碍相关。
研究设计与样本
- 横断面研究,纳入2005-2006年美国国家健康与营养调查中5563名≥18岁且完成过敏与睡眠问卷的参与者。
主要发现
- 变应性鼻炎加权患病率为36.5%。
- 调整年龄、性别、种族和肥胖后,变应性鼻炎与睡眠潜伏期≥30分钟(OR 1.24;95%CI 1.01-1.51;p=0.04)相关。
- 变应性鼻炎与睡眠呼吸暂停(OR 1.86;95%CI 1.22-2.82;p<0.01)和失眠(OR 1.85;95%CI 1.04-3.32;p=0.04)相关。
- 变应性鼻炎与入睡困难(OR 1.43;95%CI 1.17-1.75;p<0.01)、夜间醒来(OR 1.49;95%CI 1.11-1.99;p=0.01)和早醒(OR 1.46;95%CI 1.20-1.79;p<0.01)相关。
- 变应性鼻炎与日间未恢复感(OR 1.76;95%CI 1.43-2.16;p<0.01)、日间过度嗜睡(OR 1.54;95%CI 1.25-1.90;p<0.01)和睡眠不足(OR 1.68;95%CI 1.41-1.99;p<0.01)相关。
关键数值与推荐
- 变应性鼻炎定义为自报花粉症和/或过去12个月鼻部症状。
- 睡眠参数包括睡眠潜伏期、睡眠时长、睡眠障碍、睡眠习惯、助眠药物使用和日间功能障碍。
临床怎么用
- 在变应性鼻炎患者的评估中应关注睡眠质量,必要时筛查失眠和睡眠呼吸暂停。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence suggests relationships between allergic rhinitis (AR) and poor sleep parameters, but population-based studies in the United States are lacking. This study investigates the relationship between AR and sleep parameters in a representative sample of U.S. adults. METHODS: Cross-sectional study of 5563 participants ≥18 years old from the 2005-2006 National Health and Nutrition Examination Survey who participated in the allergy and sleep questionnaires. The predictor variable was AR (self-reported hay fever and/or nasal symptoms in the past 12 months). The outcome variables were individual sleep parameters (sleep latency, sleep duration, sleep disorders, sleep habits, sleep medication use, daytime dysfunction). Covariates included age, gender, race, and obesity. RESULTS: The population-weighted prevalence of AR was 36.5%. Adjusting for covariates, subjects with AR had higher odds of sleep latency ≥30 minutes (OR 1.24; 95% CI, 1.01 to 1.51; p = 0.04), sleep apnea (OR 1.86; 95% CI, 1.22 to 2.82; p < 0.01), insomnia (OR 1.85; 95% CI, 1.04 to 3.32; p = 0.04), trouble falling asleep (OR 1.43; 95% CI, 1.17 to 1.75; p < 0.01), waking up during the night (OR 1.49; 95% CI, 1.11 to 1.99; p = 0.01), waking up too early in the morning (OR 1.46; 95% CI, 1.20 to 1.79; p < 0.01), feeling unrested during the day (OR 1.76, 95% CI, 1.43 to 2.16; p < 0.01), feeling overly sleeping during the day (OR 1.54; 95% CI, 1.25 to 1.90; p < 0.01), not getting enough sleep (OR 1.68; 95% CI, 1.41 to 1.99; p < 0.01), using sleep medication (OR 1.69; 95% CI, 1.23 to 2.33; p < 0.01), difficulty concentrating (OR 1.93; 95% CI, 1.30 to 2.88; p < 0.01), remembering (OR 1.91; 95% CI, 1.22 to 2.97; p < 0.01), managing finances (OR 1.68; 95% CI, 1.09 to 2.56; p = 0.02), working (OR 2.16; 95% CI, 1.45 to 3.22; p < 0.01), and getting things done (OR 2.35; 95% CI, 1.36 to 4.06; p < 0.01) due to daytime sleepiness. CONCLUSION: This analysis of a representative sample of U.S. adults revealed associations between AR and poor sleep parameters including prolonged sleep latency, insomnia, sleep apnea, sleep disturbances, sleep medication use, and daytime dysfunction. These findings reinforce the need to assess sleep quality in patients undergoing evaluation for AR.
引用
- Roxbury CR, Qiu M, Shargorodsky J, et al. Association between allergic rhinitis and poor sleep parameters in U.S. adults. Int Forum Allergy Rhinol. 2018. PMID: 29979840. doi:10.1002/alr.22174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。